#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Optic glioma Arginase deficiency Anal cancer Erythema Cutaneous T-cell lymphoma stage II Acute respiratory distress syndrome Cardiac failure acute Immunoglobulin G4 related disease Acute graft versus host disease Antithrombin III deficiency Mucopolysaccharidosis I Angiosarcoma non-metastatic Pyruvate kinase deficiency anaemia Renal disorder Peritoneal mesothelioma malignant More trials…

    Learn about Rare Diseases

    CADASIL Propionic acidaemia Anaplastic thyroid cancer – Basic Information Rhabdomyosarcoma – Trials in Disease Turner’s syndrome – Trials in Disease Pulmonary sarcoidosis – Trials in Disease Hepatic angiosarcoma Advanced systemic mastocytosis – Treatment Andersen-Tawil syndrome – Treatment Mastocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mva-209-Fsp-B1 Mbf-015 Imlifidase Dactylis Glomerata Iberdomide Efgartigimod Alfa Rbl015.2 Sodium Oxybate PEGZILARGINASE Letetresgene Autoleucel Soticlestat GOVORESTAT Dasatinib HUMAN PLASMA Atomoxetine Hydrochloride Bi 3720931 2-DEOXY-D-GLUCOSE Pembrolizumab Ginisortamab Vobramitamab Duocarmazine More therapies…

    Learn about Your Condition

    Alcohol abuse Acoustic neuroma Colon cancer metastatic Andersen-Tawil syndrome Ischaemic stroke Hypocalcaemia Follicular lymphoma stage II Fracture infection Cutaneous T-cell lymphoma Vulvovaginal dryness Synovial sarcoma Lip and/or oral cavity cancer Conjunctivitis Palmoplantar pustulosis Adrenoleukodystrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Metabolism

  • Study on How Evolocumab and Atorvastatin Affect Cholesterol and Bile Acid Metabolism in Healthy Volunteers

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Atorvastatin
    • Evolocumab
    Sweden

  • Study on Metformin and Metformin Hydrochloride for Overweight Adults with Polycystic Ovary Syndrome

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    Investigated Drugs:
    • Metformin Hydrochloride
    • Metformin
    Finland

  • A study testing DII235 compared to placebo in adults with high lipoprotein(a) levels to reduce heart disease risk

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Glucose Monohydrate
    • Sodium Chloride
    Germany

  • Study of VS-01 with different treatment times compared to standard care alone in patients with overt hepatic encephalopathy and liver cirrhosis complications

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Citric Acid, Anhydrous Ph. Eur.
    Belgium France Germany Spain

  • Study on the Effects of Ertugliflozin and Semaglutide on Heart Health in Patients with Type 2 Diabetes

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Canagliflozin
    • Ertugliflozin
    • Insulin Aspart
    Italy

  • Study on Morphine, Lidocaine, and Naloxone for Patients with Obesity and Sleep Apnea

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Metabolic surgery
    Investigated Drugs:
    • Naloxone Hydrochloride
    • Lidocaine Hydrochloride
    • Morphine Hydrochloride
    Denmark
Previous Page
1 2 3 4 5 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!